Ocugen to commercialise Covaxin in Mexico, working on US market too

Covaxin has EUA in Mexico for use in adults; data submitted for EUA for children aged 2-18 years

Nasdaq-listed biotechnology firm Ocugen Inc will now commercialise Covaxin in Mexico. The firm is already a partner of Hyderabad-based Bharat Biotech for commercialising the Covid19 vaccine in the US territory.

Bharat Biotech today said that it has entered into an amendment to its co-development, supply and commercialisation agreement to expand Ocugen's exclusive territory to include commercialisation of Covaxin in Mexico. This gives Ocugen the commercialisation rights for all of North America for the formulation.

“We’re excited about commercialising Covaxin in Mexico, as authorities there have made conquering this pandemic a major priority. After meeting with Mexico’s Secretary of Foreign Affairs, Marcelo Ebrard,